Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy

• Status: NOT_YET_RECRUITING
• Trial end date: 2028-07-30

Summary

This study aims to evaluate the superiority of an integrated traditional Chinese and Western medicine regimen ("Xiehe DOR Bushen Tongzhi Formula" + ovulation induction therapy with ovulation monitoring and timed intercourse) compared to standard treatment alone (placebo + ovulation induction therapy with ovulation monitoring and timed intercourse) in improving the natural cumulative clinical pregnancy rate in infertile patients with kidney deficiency-type diminished ovarian reserve (DOR).

• Phase: PHASE3

Details

• Lead Sponsor: Peking Union Medical College Hospital
• Collaborators: Beijing Obstetrics and Gynecology Hospital; Beijing University of Chinese Medicine; Dongfang Hospital Beijing University of Chinese Medicine; First Affiliated Hospital of Heilongjiang Chinese Medicine University; Guangdong Provincial Hospital of Traditional Chinese Medicine; Hunan Provincial Maternal and Child Health Care Hospital; Hunan University of Traditional Chinese Medicine; Institute of Basic Medical Sciences CAMS; Shandong University; Shenyang Women's and Children's Hospital; Shunde Women and Children's Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan); The Affiliated Hospital of Shandong University of Traditional Chinese Medicine; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; The First Affiliated Hospital of Zhengzhou University; The Third Affiliated Hospital of Beijing University of Chinese Medicine; Xiamen University; Xiyuan Hospital of China Academy of Chinese Medical Sciences
• Treatments: Medicine, Chinese Traditional